Overview

Definition:
-May-Thurner syndrome (MTS), also known as the iliac vein compression syndrome, is an anatomical variant where the right common iliac artery compresses the left common iliac vein against the lumbar spine
-This compression can lead to chronic venous stasis, increased risk of deep vein thrombosis (DVT) in the left leg, and chronic venous insufficiency
-Iliac vein stenting is a minimally invasive endovascular procedure to relieve this obstruction.
Epidemiology:
-The exact prevalence of MTS is difficult to determine due to asymptomatic cases and variability in diagnostic criteria
-Autopsy studies suggest compression in 15-30% of individuals
-Symptomatic MTS is less common, but it is a recognized cause of left-sided DVT, particularly in younger individuals (20-50 years old) and women, often associated with pregnancy or oral contraceptive use
-It is estimated to be the underlying cause in up to 80% of left-sided iliofemoral DVTs.
Clinical Significance:
-Untreated MTS can lead to significant morbidity, including chronic leg swelling, pain, skin changes (hyperpigmentation, stasis dermatitis), venous ulcers, and a substantially increased risk of recurrent DVT and pulmonary embolism
-Early diagnosis and appropriate intervention, such as stenting, are crucial to restore venous outflow, alleviate symptoms, prevent post-thrombotic syndrome, and improve long-term quality of life.

Clinical Presentation

Symptoms:
-Left leg swelling (edema)
-Leg pain, particularly with activity (claudication)
-Heaviness or aching in the left leg
-Skin changes on the left leg: hyperpigmentation, induration, or venous ectasias
-Varicose veins in the left leg or pelvic region
-Increased risk of deep vein thrombosis (DVT) presenting as acute pain, swelling, warmth, and tenderness in the left leg.
Signs:
-Unilateral edema of the left lower extremity
-Dilated superficial veins on the left leg or trunk
-Palpable cords of thrombosed superficial veins
-Tenderness over the iliofemoral venous system
-Signs of chronic venous insufficiency: stasis dermatitis, lipodermatosclerosis, or venous ulcers
-Homan's sign (unreliable but may be positive in acute DVT).
Diagnostic Criteria:
-There are no universally established diagnostic criteria for MTS, but a diagnosis is typically suspected in patients with unexplained left-sided iliofemoral DVT or chronic venous insufficiency
-Diagnosis is confirmed by objective venous imaging demonstrating significant compression of the left common iliac vein by the right common iliac artery, particularly during venography or intravascular ultrasound (IVUS), with evidence of venous obstruction and collateral formation
-A pressure gradient across the compressed segment (>2 mmHg at rest, or >5 mmHg with Valsalva or exercise) is often considered diagnostic.

Diagnostic Approach

History Taking:
-Detailed history of unilateral leg swelling or pain
-Onset, duration, and progression of symptoms
-Associated risk factors for DVT: immobility, surgery, trauma, malignancy, hypercoagulable states, oral contraceptive use, pregnancy
-Previous history of DVT or venous insufficiency
-Family history of venous thromboembolic disease
-Prior interventions for venous disease
-Red flags: acute onset of severe pain and swelling suggesting acute DVT.
Physical Examination:
-Bilateral leg circumference measurements to assess edema
-Assess for pitting edema, skin texture, color, and temperature
-Palpate for venous cords or tenderness
-Examine for superficial venous dilation and varicosities
-Assess for signs of post-thrombotic syndrome (lipodermatosclerosis, venous ulcers)..
Investigations:
-Duplex ultrasonography: Initial non-invasive test to evaluate for DVT and assess venous flow and patency
-May show flow disturbances at the iliac vein confluence
-Computed Tomography Venography (CTV) or Magnetic Resonance Venography (MRV): Provide detailed anatomical visualization of the iliac veins and arteries, demonstrating compression and collateral formation
-Intravascular Ultrasound (IVUS): Gold standard for quantifying the degree of iliac vein compression and assessing venous wall morphology
-It can measure the pressure gradient across the stenosis
-Conventional Venography: Historically the gold standard, performed during intervention, showing the extent of stenosis, thrombus, and collateralization.
Differential Diagnosis:
-Deep vein thrombosis (DVT) of left leg due to other causes (e.g., hypercoagulable state, extrinsic compression from mass)
-Pelvic tumors compressing the iliac vein
-Gynecological conditions (e.g., ovarian hyperstimulation syndrome, pregnancy-related venous compression)
-Retroperitoneal fibrosis
-Iliac artery aneurysm
-Lymphadenopathy
-Superficial thrombophlebitis
-Chronic venous insufficiency from other causes.

Management

Initial Management:
-For acute DVT, initial management includes anticoagulation (e.g., unfractionated heparin followed by warfarin or direct oral anticoagulants (DOACs)) to prevent further clot propagation and reduce the risk of PE
-For symptomatic chronic venous compression without acute DVT, initial management may involve conservative measures like compression therapy and anticoagulation if indicated for recurrent DVT risk.
Medical Management:
-Anticoagulation is the mainstay for acute DVT
-Warfarin (target INR 2.0-3.0) or DOACs (e.g., rivaroxaban, apixaban, dabigatran, edoxaban) are used for 3-6 months or longer, depending on risk factors and recurrence
-For chronic symptoms, graded compression stockings (Class II or III) are essential
-Pharmacomechanical thrombolysis may be considered in select cases of severe acute DVT with limb-threatening ischemia or massive DVT to facilitate subsequent stenting.
Surgical Management:
-Endovascular intervention is the preferred treatment for symptomatic MTS
-This involves iliac vein stenting
-Indications include significant left iliofemoral venous obstruction causing symptoms, a pressure gradient across the stenosis (>2 mmHg at rest or >5 mmHg with maneuvers), and failure of conservative management
-The procedure typically involves venography, IVUS assessment, angioplasty, and placement of a self-expanding stent (e.g., Wallstent, Viabahn) across the compressed segment
-Thrombus aspiration or thrombectomy may precede stenting in cases of acute DVT
-Open surgical reconstruction (e.g., Palma procedure) is rarely performed for MTS and reserved for complex cases not amenable to endovascular treatment.
Supportive Care:
-Elevation of the affected limb
-Graduated compression stockings
-Regular ambulation and exercise to promote venous return
-Skin care to prevent breakdown and manage stasis dermatitis
-Patient education on lifestyle modifications and recognition of recurrent DVT symptoms.

Complications

Early Complications:
-Bleeding at the access site (groin hematoma, pseudoaneurysm)
-Arteriovenous fistula at the access site
-Stent migration or embolization
-In-stent thrombosis (acute)
-Allergic reaction to contrast media
-Renal injury from contrast
-Femoral vein injury
-Dissection of the iliac vein or artery.
Late Complications:
-In-stent restenosis due to neointimal hyperplasia or chronic thrombosis
-Chronic venous stenosis or occlusion
-Post-thrombotic syndrome (PTS) despite successful stenting
-Recurrent DVT
-Chronic venous insufficiency
-Pain and swelling refractory to treatment.
Prevention Strategies:
-Meticulous technique during endovascular access and stent deployment
-Appropriate stent selection based on venous anatomy and lesion characteristics
-Aggressive anticoagulation post-stenting, especially in cases of acute DVT
-Adherence to long-term anticoagulation as prescribed
-Long-term use of compression stockings
-Regular follow-up with duplex ultrasound to monitor stent patency and detect early signs of restenosis.

Prognosis

Factors Affecting Prognosis:
-Timeliness of diagnosis and intervention
-Presence and extent of acute DVT at presentation
-Success of the stenting procedure (achieving good lumen gain and favorable pressure gradient)
-Adherence to anticoagulation and compression therapy
-Presence of underlying hypercoagulable states
-Degree of pre-existing venous damage and post-thrombotic changes.
Outcomes:
-With successful iliac vein stenting, most patients experience significant symptom relief, including reduced leg swelling, pain, and improved quality of life
-Long-term patency rates for iliac vein stents in MTS are generally high (80-90% at 5 years), especially when treating isolated venous compression without extensive chronic DVT
-Patients with pre-existing significant PTS may have less dramatic improvement but can still benefit from reduced symptom burden.
Follow Up:
-Lifelong follow-up is generally recommended
-Initial follow-up typically involves duplex ultrasound at 1, 3, 6, and 12 months post-procedure, then annually or as needed
-Regular clinical assessment for recurrence of symptoms or signs of venous insufficiency
-Emphasis on continued use of compression stockings and appropriate anticoagulation
-Patients should be educated on signs of recurrent DVT and advised to seek immediate medical attention.

Key Points

Exam Focus:
-MTS is defined by compression of the left common iliac vein by the right common iliac artery, leading to left-sided DVT/venous insufficiency
-Imaging of choice for diagnosis: MRV/CTV, IVUS confirms and quantifies
-Treatment of choice for symptomatic MTS: iliac vein stenting
-Anticoagulation is critical for acute DVT and post-stenting
-Complications include in-stent thrombosis/restenosis and PTS.
Clinical Pearls:
-Suspect MTS in young patients with isolated left lower extremity DVT or chronic venous insufficiency
-Always assess for a pressure gradient across the iliac vein confluence, especially during venography or IVUS
-Consider caval filters only if there is contraindication to stenting and high risk of PE
-Stent placement should ideally restore venous flow and minimize pressure gradient
-Long-term compliance with anticoagulation and compression is vital for successful outcomes.
Common Mistakes:
-Misdiagnosing MTS as isolated DVT without investigating the iliac vein confluence
-Delaying intervention in acute iliofemoral DVT due to MTS, leading to increased PTS
-Inadequate anticoagulation post-stenting, increasing risk of in-stent thrombosis
-Forgetting to check for a pressure gradient, leading to undertreatment or overtreatment
-Underestimating the importance of long-term compression therapy and patient adherence.